{"news_desk": "National", "print_page": "19", "section_name": "Health", "subsection_name": null, "byline": {"original": "By DENISE GRADY", "person": [{"rank": 1, "role": "reported", "firstname": "Denise", "organization": "", "lastname": "GRADY"}]}, "abstract": "Studies in New England Journal of Medicine conclude drugs nivolumab and cabozantinib work better than standard drug everolimus in treatment of advanced kidney cancer; findings are likely to lead to changes in patient care.", "type_of_material": "News", "word_count": "915", "lead_paragraph": "Studies of two drugs, showing that each works better than the standard treatment for advanced kidney cancer, should lead to changes in patient care, researchers said.", "pub_date": "2015-09-26T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "New Drugs Prove More Effective in Treatment of Kidney Cancer, Studies Find", "print_headline": "New Drugs Prove More Effective in Treatment of Kidney Cancer, Studies Find"}, "snippet": "Studies of two drugs, showing that each works better than the standard treatment for advanced kidney cancer, should lead to changes in patient care, researchers said.", "multimedia": [{"height": 126, "url": "images/2015/09/26/science/26KIDNEY/26KIDNEY-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/09/26/science/26KIDNEY/26KIDNEY-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/09/26/science/26KIDNEY/26KIDNEY-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/09/26/science/26KIDNEY/26KIDNEY-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/09/26/science/26KIDNEY/26KIDNEY-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/09/26/science/26KIDNEY/26KIDNEY-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/09/26/health/2-new-drugs-prove-more-effective-against-kidney-cancer-studies-find.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Kidney Cancer", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "New England Journal of Medicine", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Exelixis Inc", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "Immune System", "name": "subject"}, {"rank": "8", "is_major": "N", "value": "Motzer, Robert J (1954- )", "name": "persons"}, {"rank": "9", "is_major": "N", "value": "Sharma, Padmanee (1970- )", "name": "persons"}, {"rank": "10", "is_major": "N", "value": "Bristol Myers Squibb Company", "name": "organizations"}], "blog": [], "_id": "5605c43838f0d809f2db1ef2", "source": "The New York Times"}